Piramal Pharma and Sai Life Sciences Rise for Third Consecutive Session on NSE
Piramal Pharma Ltd and Sai Life Sciences Ltd both gained for the third consecutive session on the NSE, with Piramal Pharma rising 1.97% to Rs 206.49 and Sai Life Sciences up 1.21% to Rs 1,383 as of midday trading. Over the past year, Piramal Pharma increased about 10.82%, while Sai Life Sciences rose approximately 74.36%, outperforming the NIFTY and Nifty Pharma index. Both stocks showed monthly gains amid a slightly declining broader market.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (50/100). Lens Score 31/100.
Outlets measured: businessstandard, businessstandard. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (50–50/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
businessstandard broke this story on 5 Aug, 08:25 am. Other outlets followed.
- 1